BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3593641)

  • 1. Cyclosporin A in systemic sclerosis.
    Zachariae H; Zachariae E
    Br J Dermatol; 1987 May; 116(5):741-2. PubMed ID: 3593641
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin A in progressive systemic sclerosis.
    Yocum DE; Wilder RL
    Am J Med; 1987 Aug; 83(2):369-70. PubMed ID: 3618643
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin collagen from scleroderma patients before and after cyclosporin A treatment.
    Francès C; Branchet MC; Blétry O; Lefevre C; Boisnic S; Kern P; Godeau P
    Clin Exp Dermatol; 1988 Jan; 13(1):1-3. PubMed ID: 3208433
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin in localized and systemic scleroderma--a clinical study.
    Wörle B; Hein R; Krieg T; Meurer M
    Dermatologica; 1990; 181(3):215-20. PubMed ID: 2269381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A treatment of systemic sclerosis.
    Zachariae H; Halkier-Sørensen L; Heickendorff L; Zachariae E; Hansen HE
    Br J Dermatol; 1990 May; 122(5):677-81. PubMed ID: 2354119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of overlap syndrome of PSS, SLE and Sjögren syndrome treated by cyclosporin A: an improvement of sclerosis of the skin].
    Kume A; Ueda K; Sano S; Funai T; Kobayashi Y; Hashimoto K; Yoshikawa K
    Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1191-6. PubMed ID: 2614988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine therapy for severe systemic sclerosis associated with the anti-Scl-70 autoantibody.
    Vayssairat M; Baudot N; Boitard C; Fiessinger JN; Bach JF
    J Am Acad Dermatol; 1990 Apr; 22(4):695-6. PubMed ID: 2319032
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine in successful control of rapidly progressive scleroderma.
    Appelboom T; Itzkowitch D
    Am J Med; 1987 Apr; 82(4):866-7. PubMed ID: 3565449
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of immunomodulating therapy in systemic sclerosis.
    van den Hoogen FH; Boerbooms AM; van de Putte LB
    Clin Rheumatol; 1990 Sep; 9(3):319-24. PubMed ID: 2124530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous malignant melanomas occurring under cyclosporin A therapy: a report of two cases.
    Mérot Y; Miescher PA; Balsiger F; Magnenat P; Frenk E
    Br J Dermatol; 1990 Aug; 123(2):237-9. PubMed ID: 2400725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive systemic sclerosis and renal transplantation: a contraindication to the use of cyclosporine A?
    Ruiz JC; Val F; de Francisco AL; de Bonis E; Zubimendi JA; Prieto M; Canga E; Sanz de Castro S; Arias M
    Transplant Proc; 1991 Aug; 23(4):2211-2. PubMed ID: 1871849
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A.
    Filaci G; Cutolo M; Basso M; Murdaca G; Derchi L; Gianrossi R; Ropolo F; Zentilin P; Sulli A; Puppo F; Indiveri F
    Rheumatology (Oxford); 2001 Dec; 40(12):1431-2. PubMed ID: 11752529
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of successful pregnancy in a woman with systemic sclerosis treated with cyclosporin.
    Basso M; Ghio M; Filaci G; Setti M; Indiveri F
    Rheumatology (Oxford); 2004 Oct; 43(10):1310-1. PubMed ID: 15448218
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of cyclosporin A on 2ry MLR in patients with progressive systemic sclerosis.
    Sabbadini MG; Scorza R; Honorati MC; Coppola C; Vanoli M; Rugarli C; Zanussi C
    Boll Ist Sieroter Milan; 1987; 66(6):466-70. PubMed ID: 2968806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A.
    Basso M; Filaci G; Cutolo M; Murdaca G; Derchi L; Gianrossi R; Ropolo F; Zentilin P; Sulli A; Puppo F; Indiveri F
    Ann Ital Med Int; 2001; 16(4):233-9. PubMed ID: 11799631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A curtails the progression of free light chain synthesis in the CSF of patients with multiple sclerosis.
    McLean BN; Rudge P; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):529-31. PubMed ID: 2500497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleroderma associated with anemia and thrombocytopenia that responded well to cyclosporin.
    Kamada K; Kobayashi Y; Katada K; Takahashi Y; Chikayama S; Ikeda M; Kondo M
    Acta Haematol; 2000; 104(2-3):106-9. PubMed ID: 11154984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma.
    Morton SJ; Powell RJ
    Rheumatology (Oxford); 2000 Aug; 39(8):865-9. PubMed ID: 10952740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.